查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2093176

新生兒重症監護呼吸器市場－2026-2032年全球市場預測

Neonatal Intensive Care Respiratory Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，新生兒重症監護呼吸器市場規模將達到 41.2 億美元，複合年成長率為 10.30%。

主要市場統計數據
基準年 2025 20.7億美元
預計年份：2026年 22.5億美元
預測年份：2032年 41.2億美元
複合年成長率 (%) 10.30%

新生兒重症監護呼吸機：執行摘要

新生兒重症監護呼吸機在早產兒和嚴重症新生兒的生存和長期預後中發揮著至關重要的作用，尤其對於患有呼吸窘迫症候群、早產兒呼吸暫停、肺支氣管發育不良、性行為感染感染、新生兒窒息和胎糞吸入症候群的患兒而言更是如此。此類別包括新生兒人工呼吸器、持續性陽壓呼吸器（CPAP）系統、高流量氧氣鼻管平台、復甦設備、氧氣輸送系統、加濕解決方案、患者介面系統、呼吸監測工具以及在新生兒加護病房、產房、轉運中心和過渡護理環境中使用的相關耗材。

新生兒呼吸照護領域的變革性變化

新生兒呼吸照護正從有創、被動的支持轉向更早期、非侵入性、更個人化的呼吸系統護理。在臨床上適宜的情況下，非侵入性通氣、氣泡式持續性正壓呼吸器（CPAP）、鼻塞式CPAP、同步無創通氣以及加溫加濕高流量氧療等技術正被擴大用於減輕插管負擔。這種轉變反映了全球臨床關注的重點，即最大限度地減少人工呼吸器相關性肺損傷、降低氧中毒風險並預防與長期有創通氣相關的併發症。

人工智慧對新生兒呼吸器的累積影響

人工智慧 (AI) 正透過決策支援、預測性監測、警報最佳化、自動記錄和封閉回路型控制等概念，開始影響新生兒呼吸護理。在新生兒重症監護中，AI 的臨床價值在於其能夠解讀從人工呼吸器、脈搏血氧飽和度分析儀、心肺監視器、血糖趨勢和護理觀察中獲得的高頻生理數據。經過檢驗並負責任地實施後，AI 工具可以幫助臨床醫生識別呼吸惡化、呼吸暫停模式、反覆氧飽和度下降、膿毒症相關不穩定進展以及人工呼吸器撤機準備等早期徵兆。

關鍵區域洞察：新生兒呼吸器部署的全球趨勢

由於亞太地區新生兒數量龐大、醫院基礎設施不斷完善，以及各國為提高新生兒存活率而採取的各項舉措，該地區成為新生兒重症監護呼吸機的重點供應區域。儘管該地區各國正在加強新生兒加護病房（NICU）的容量、氧氣供應系統和分銷網路，但先進的三級醫療機構和資源匱乏的農村醫療機構之間的需求仍然存在差異。該地區的採購需求通常需要在人工呼吸器平台和堅固耐用、易於維護且經濟高效的持續性正壓呼吸器（CPAP）及氧氣療法方案之間取得平衡。

關鍵集團洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團與北約的趨勢

在東協，隨著婦幼保健水準的全面提升，新生兒重症監護服務也不斷發展。該地區既擁有高度發展的都市區醫院，也有一些醫療機構仍在努力加強氧氣基礎設施、新生兒轉運系統以及訓練有素的呼吸護理人員團隊。因此，需求範圍從三級醫療機構所需的高級新生兒人工呼吸器（CPAP）、氧氣混合、加濕和復甦解決方案，不一而足。

重點國家洞察：主要市場新生兒呼吸器優先事項

美國擁有高度發展的新生兒加護體系，能夠廣泛獲得先進的人工呼吸器、非侵入性呼吸支援、新生兒監護和專業的呼吸治療技術。醫療設備的普及應用受到品質指標、報銷機制、病患安全標準、互通性以及人們對人工智慧驅動的監護和自動氧氣控制日益成長的興趣等因素的影響。加拿大同樣重視實證新生兒護理、社區周產期網路以及地理分散人口的公平醫療服務獲取，因此設備的可靠性、培訓和轉運能力是關鍵的考量。

新生兒呼吸器領域領導者使用的實用建議

產業領導者應優先考慮新生兒專用設計，而非簡單地沿用成人或兒童平台。醫療設備必須能夠適應極低出生體重兒，提供小潮氣量、高靈敏度觸發、精確的壓力輸送、漏氣補償、親膚界面、穩定的加濕以及精準的氧氣混合功能。為了減輕訓練負擔並主動預防工作流程中的安全風險，應從研發初期就納入由新生兒科醫師、呼吸治療師、護理師和生物醫學工程師參與的可用性測試。

取得新生兒呼吸器實證知識的調查方法

本執行摘要基於系統的二手資料研究途徑，使用了檢驗的公共領域和機構資料，內容涉及新生兒呼吸護理、母嬰健康、醫療設備法規、臨床實踐標準和醫療保健基礎設施。資訊來源包括世界衛生組織、各國衛生部門、經同儕審查的新生兒和呼吸護理文獻、監管指南、臨床指南庫以及公開的醫院和醫療保健系統文件。

結論：促進更安全、更公平的新生兒呼吸照護。

新生兒加護病房中的呼吸器正從單純的獨立維生設備發展成為整合化、數據驅動且生理特異性的系統，旨在提升最脆弱患者的安全。其最大的發展機會在於非侵入性呼吸支援、精準氧氣管理、新生兒專用通氣模式、進階監測、轉運功能、感染預防以及檢驗的AI驅動決策支援。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 新生兒加護呼吸器市場：依產品類型分類

  • 持續性陽壓呼吸器（CPAP）裝置
  • 傳統人工呼吸器
  • 高頻人工呼吸器
  • 氧氣罩

第8章 新生兒加護呼吸器市場：依技術分類

  • 侵入性呼吸支持
    • 常規機械通氣
      • 雙控機械通氣
      • 壓力控制機械通氣
      • 容量控制機械通氣
    • 高頻振動通風
  • 非侵入性呼吸支持
    • 持續陽壓呼吸器治療
    • 非侵入性正壓通氣

第9章 新生兒加護呼吸器市場：依模式分類

  • 雙控機械通氣
  • 壓力控制機械通氣
  • 容量控制機械通氣

第10章 新生兒加護呼吸器市場：依最終用戶分類

  • 診所
  • 醫院
  • 專科護理中心

第11章 新生兒加護呼吸器市場：依應用領域分類

  • 呼吸暫停監測
  • 氧氣療法
  • 提款支持

第12章 新生兒加護呼吸器市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 新生兒加護呼吸器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 新生兒加護呼吸器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Allied Healthcare Products Inc.
  • Atom Medical Corporation
  • AVI Healthcare Private Limited
  • Becton, Dickinson and Company
  • Dragerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • Fanem Ltda
  • Fisher & Paykel Healthcare Corporation Limited
  • GaleMed Corporation
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • Hamilton Medical AG
  • ICU Medical Inc.
  • Inspiration Healthcare Group plc
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medin Medical Innovations GmbH
  • Medtronic plc
  • Mindray Medical International Limited
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Nonin Medical Inc.
  • Phoenix Medical Systems Private Limited
  • ResMed Inc.
  • Sechrist Industries Inc.
  • Siare Engineering International Group srl
  • SLE Limited
  • Utah Medical Products Inc.
  • Vyaire Medical Inc.
Product Code: MRR-925E8149CBB7

The Neonatal Intensive Care Respiratory Devices Market is projected to grow by USD 4.12 billion at a CAGR of 10.30% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.07 billion
Estimated Year [2026] USD 2.25 billion
Forecast Year [2032] USD 4.12 billion
CAGR (%) 10.30%

Neonatal Intensive Care Respiratory Devices: Executive Summary

Neonatal intensive care respiratory devices are central to the survival and long-term outcomes of premature and critically ill newborns, particularly those affected by respiratory distress syndrome, apnea of prematurity, bronchopulmonary dysplasia, congenital infections, birth asphyxia, and meconium aspiration. The category spans neonatal ventilators, continuous positive airway pressure systems, high-flow nasal cannula platforms, resuscitation devices, oxygen delivery systems, humidification solutions, patient interfaces, respiratory monitoring tools, and related consumables used across neonatal intensive care units, delivery rooms, transport settings, and step-down care environments.

Demand is shaped by well-documented clinical needs: preterm infants have structurally and functionally immature lungs, reduced surfactant production, limited respiratory muscle endurance, and a high risk of oxygen instability. At the same time, neonatal care standards increasingly emphasize lung-protective ventilation, non-invasive respiratory support, precision oxygen control, infection prevention, and family-centered developmental care. Health systems are also investing in neonatal critical care capacity as part of broader maternal and newborn health goals, especially in regions working to reduce preventable neonatal mortality.

The executive outlook for neonatal intensive care respiratory devices is defined by clinical safety, usability, interoperability, and equity of access. Purchasing decisions are increasingly influenced by evidence-based protocols, biomedical engineering readiness, staff training requirements, oxygen infrastructure, consumable availability, and regulatory compliance. Industry stakeholders that align product design with neonatal physiology, workflow realities, and outcomes-driven care pathways are best positioned to support neonatal teams and expand access to safer respiratory support.

Transformative Shifts in the Neonatal Respiratory Care Landscape

The neonatal respiratory care landscape is moving from invasive, reactive support toward earlier, gentler, and more individualized respiratory management. Non-invasive ventilation, bubble CPAP, nasal CPAP, synchronized non-invasive ventilation, and heated humidified high-flow therapy are increasingly used to reduce intubation exposure when clinically appropriate. This shift reflects global clinical emphasis on minimizing ventilator-induced lung injury, reducing oxygen toxicity, and preventing complications associated with prolonged invasive ventilation.

Device innovation is also being shaped by the need for precision. Neonates require tight oxygen targeting because both hypoxemia and hyperoxemia are associated with serious adverse outcomes, including neurodevelopmental injury and retinopathy of prematurity. As a result, respiratory devices are incorporating improved sensors, automated oxygen control features, leak compensation, advanced alarms, humidification stability, and neonatal-specific ventilation modes. Interfaces are evolving as well, with greater attention to skin integrity, nasal trauma prevention, comfort, and secure fit for extremely low birth weight infants.

Operationally, neonatal intensive care units are prioritizing devices that reduce workflow burden and support standardized protocols. Transport-capable respiratory systems, compact designs, battery resilience, simplified user interfaces, and compatibility with electronic health records are gaining strategic relevance. Infection prevention remains a major design and procurement consideration, particularly for breathing circuits, humidifiers, filters, and reusable components. The landscape is also being transformed by value-based procurement, where durability, serviceability, training, and total cost of ownership are evaluated alongside clinical performance.

Cumulative Impact of Artificial Intelligence in Neonatal Respiratory Devices

Artificial intelligence is beginning to influence neonatal respiratory care through decision support, predictive monitoring, alarm optimization, automated documentation, and closed-loop control concepts. In neonatal intensive care, the clinical value of AI lies in its ability to interpret high-frequency physiologic data from ventilators, pulse oximeters, cardiorespiratory monitors, blood gas trends, and nursing observations. When validated and responsibly implemented, AI-enabled tools can help clinicians identify early signs of respiratory deterioration, apnea patterns, oxygen desaturation clusters, evolving sepsis-related instability, and weaning readiness.

The cumulative impact of AI is most visible in three areas. First, predictive analytics can support earlier intervention by highlighting subtle changes that may not be apparent in intermittent assessments. Second, AI-assisted alarm management can reduce alarm fatigue by improving signal relevance and prioritizing clinically meaningful events. Third, closed-loop or semi-automated oxygen control can support tighter oxygen saturation targeting, an important need in premature infants vulnerable to both under-oxygenation and oxygen-related injury.

However, AI adoption in neonatal intensive care requires rigorous validation because newborns, especially extremely preterm infants, have rapidly changing physiology and narrow safety margins. Algorithms must be trained and evaluated on representative neonatal populations, including diverse gestational ages, birth weights, disease states, and care settings. Transparent performance reporting, human oversight, cybersecurity, interoperability, and bias mitigation are essential. AI should augment-not replace-clinical expertise, with respiratory therapists, neonatologists, nurses, and biomedical teams remaining central to decision-making and safety governance.

Key Regional Insights: Global Dynamics in Neonatal Respiratory Device Adoption

Asia-Pacific is a high-priority region for neonatal intensive care respiratory devices due to its large birth cohort, expanding hospital infrastructure, and national efforts to improve newborn survival. Countries across the region are strengthening neonatal intensive care unit capacity, oxygen delivery systems, and referral networks, while demand remains diverse between advanced tertiary centers and resource-constrained rural facilities. The region's procurement needs often balance advanced ventilatory platforms with robust, maintainable, and cost-efficient CPAP and oxygen therapy solutions.

North America is characterized by mature neonatal intensive care capabilities, high adoption of advanced ventilation and monitoring technologies, and strong emphasis on evidence-based neonatal respiratory protocols. Hospitals in the United States and Canada prioritize precision oxygen management, interoperability, clinical documentation, staff training, and compliance with stringent safety standards. The region is also an important environment for adoption of AI-enabled monitoring, automated oxygen control, and integrated neonatal care platforms.

Latin America shows growing attention to neonatal survival, maternal-child health programs, and modernization of critical care infrastructure. Respiratory device adoption is influenced by public hospital funding, regional disparities in NICU availability, biomedical maintenance capabilities, and access to consumables. Brazil and Mexico anchor regional demand, while broader adoption is supported by initiatives to improve neonatal resuscitation, safe oxygen use, and non-invasive respiratory support.

Europe demonstrates strong clinical standardization, regulatory oversight, and adoption of lung-protective neonatal respiratory care. Many European health systems emphasize quality improvement, infection prevention, advanced monitoring, and long-term neurodevelopmental outcomes. Procurement decisions are often influenced by safety, interoperability, environmental sustainability, lifecycle service support, and compliance with medical device regulations.

The Middle East is investing in advanced tertiary care hospitals, maternal-fetal medicine, and neonatal intensive care capacity, particularly across high-income Gulf countries. Demand centers on premium ventilation, transport incubator-compatible respiratory systems, monitoring integration, and specialist training. At the same time, access varies across the wider region, creating opportunities for scalable respiratory support technologies suited to both advanced and developing neonatal care environments.

Africa faces the highest urgency for equitable neonatal respiratory care expansion because preventable neonatal mortality remains closely linked to prematurity, birth complications, infections, and limited access to oxygen and respiratory support. Device needs are strongly tied to reliable oxygen infrastructure, safe CPAP implementation, power stability, equipment maintenance, and workforce training. Durable, easy-to-use, low-maintenance neonatal respiratory devices can have substantial clinical relevance when embedded within quality newborn care systems.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO Trends

ASEAN countries are expanding neonatal intensive care services alongside broader improvements in maternal and child health. The region contains both advanced urban hospitals and facilities still strengthening oxygen infrastructure, neonatal transport, and trained respiratory care capacity. As a result, demand spans sophisticated neonatal ventilators in tertiary centers and practical CPAP, oxygen blending, humidification, and resuscitation solutions in district and provincial hospitals.

The GCC is marked by strong investment in tertiary healthcare infrastructure, specialized neonatal units, and advanced medical technologies. Neonatal respiratory device purchasing in this group is influenced by high standards for clinical performance, integration with hospital information systems, comprehensive service contracts, and training programs for multidisciplinary neonatal teams. Demand is particularly aligned with advanced ventilation, non-invasive respiratory support, and neonatal transport readiness.

The European Union places significant emphasis on patient safety, regulatory compliance, standardized clinical pathways, and healthcare quality improvement. Neonatal respiratory devices in EU member states must align with rigorous medical device regulation, post-market surveillance expectations, and hospital procurement frameworks that consider safety, usability, serviceability, and sustainability. The EU environment supports adoption of evidence-backed respiratory support technologies and interoperable monitoring systems.

BRICS countries collectively represent a wide spectrum of neonatal respiratory care needs, from large tertiary networks to under-resourced settings requiring scalable solutions. China and India have substantial birth volumes and active efforts to improve neonatal care access, while Brazil, Russia, and South Africa face distinct infrastructure, workforce, and regional equity challenges. Across BRICS, opportunities are tied to local manufacturing capacity, public health investment, affordable respiratory support, and training-enabled implementation.

G7 countries generally have mature neonatal intensive care systems, strong regulatory oversight, and advanced clinical adoption of neonatal ventilation, oxygen control, and monitoring technologies. Their device priorities include safety, interoperability, data integration, reduced clinician burden, and support for quality metrics. These countries are also important early adopters of validated digital and AI-supported neonatal respiratory solutions.

NATO member countries span North America and Europe, with neonatal respiratory device needs shaped by both civilian healthcare systems and, in some contexts, emergency preparedness and medical logistics. Transportable respiratory support, resilient supply chains, standardized equipment training, and interoperability are relevant considerations. Within NATO health systems, advanced NICU care coexists with increasing attention to supply continuity, cybersecurity, and critical care readiness.

Key Country Insights: Neonatal Respiratory Device Priorities Across Major Markets

The United States has a highly developed neonatal intensive care ecosystem with widespread access to advanced ventilators, non-invasive respiratory support, neonatal monitoring, and specialized respiratory therapy expertise. Device adoption is influenced by quality metrics, reimbursement structures, patient safety standards, interoperability, and growing interest in AI-assisted monitoring and automated oxygen control. Canada similarly emphasizes evidence-based neonatal care, regionalized perinatal networks, and equitable access across geographically dispersed populations, making device reliability, training, and transport capability important considerations.

Mexico is strengthening neonatal care capacity through public and private healthcare investment, with demand shaped by urban-rural disparities, NICU availability, and the need for cost-effective respiratory support. Brazil serves as a major Latin American healthcare hub, where neonatal respiratory device needs are influenced by large public health networks, private hospital modernization, and regional differences in access to specialized neonatal services.

The United Kingdom prioritizes neonatal network coordination, standardized clinical guidance, and quality improvement across neonatal units, supporting adoption of lung-protective ventilation, non-invasive respiratory care, and integrated monitoring. Germany has a strong advanced medical technology environment and well-established neonatal intensive care services, with procurement focused on safety, performance, and regulatory compliance. France emphasizes specialized neonatal care pathways and public health quality initiatives, while Italy and Spain combine advanced tertiary neonatal services with regionalized healthcare delivery models that influence procurement and standardization. Russia's neonatal respiratory device landscape reflects a large geographic healthcare system, where access to advanced NICU technologies varies across metropolitan and remote regions.

China is expanding and upgrading neonatal intensive care capacity across major hospitals while working to improve access in lower-tier cities and regional centers. The country's neonatal respiratory needs include advanced ventilators, non-invasive support, oxygen control, monitoring integration, and scalable solutions for broader newborn care coverage. India has one of the world's largest newborn populations and a strong public health focus on reducing neonatal mortality, creating substantial need for affordable, durable, easy-to-maintain CPAP, oxygen therapy, resuscitation, and ventilation systems supported by training and service networks.

Japan has a sophisticated neonatal care system with strong attention to precision, safety, and advanced monitoring, supporting adoption of high-performance respiratory platforms and compact NICU-compatible technologies. Australia benefits from regionalized perinatal care, advanced neonatal retrieval systems, and strong clinical governance, making transport-compatible respiratory support and remote-area service readiness important. South Korea combines advanced hospital infrastructure with rapid technology adoption, supporting demand for integrated neonatal ventilation, monitoring, and digital respiratory care solutions.

Actionable Recommendations for Neonatal Respiratory Device Leaders

Industry leaders should prioritize neonatal-specific design rather than adapting adult or pediatric platforms. Devices must support extremely low birth weight infants, small tidal volumes, sensitive triggering, accurate pressure delivery, leak compensation, gentle interfaces, stable humidification, and precise oxygen blending. Usability testing with neonatologists, respiratory therapists, nurses, and biomedical engineers should be embedded early in development to reduce training burden and prevent workflow-related safety risks.

Manufacturers and suppliers should expand evidence generation through multicenter clinical evaluations, real-world usability studies, and post-market safety surveillance focused on neonatal outcomes. Demonstrating reduced intubation exposure, improved oxygen targeting, fewer interface injuries, lower alarm burden, and easier protocol adherence can strengthen clinical adoption without relying on cost or volume claims.

For growth across diverse healthcare settings, companies should build tiered portfolios that include advanced NICU systems as well as robust CPAP, oxygen therapy, resuscitation, and transport solutions for resource-limited environments. Local service capacity, spare parts availability, consumable continuity, and biomedical training are critical differentiators. Partnerships with hospitals, professional societies, and public health programs can improve implementation quality and long-term device utilization.

Digital strategy should focus on validated, interoperable, and clinician-supervised tools. AI features should be transparent, explainable, and tested across neonatal subgroups. Cybersecurity, data privacy, and integration with electronic medical records are essential for hospital acceptance. Finally, industry leaders should align with sustainability goals by reducing disposable waste where clinically safe, improving device durability, and supporting responsible end-of-life management.

Research Methodology for Evidence-Based Neonatal Respiratory Device Insights

This executive summary is built on a structured secondary research approach using verified public-domain and institutional sources related to neonatal respiratory care, maternal and newborn health, medical device regulation, clinical practice standards, and healthcare infrastructure. Sources considered include global health agencies, national health authorities, peer-reviewed neonatal and respiratory care literature, regulatory guidance, clinical guideline repositories, and publicly available hospital and health system documentation.

The methodology emphasizes triangulation across clinical, regulatory, technological, and regional evidence. Key themes were validated by comparing neonatal respiratory disease burden, preterm birth relevance, NICU care practices, oxygen therapy standards, non-invasive ventilation adoption, device safety considerations, and health system capacity indicators. Regional, group, and country insights were developed through qualitative synthesis of healthcare infrastructure patterns, newborn health priorities, regulatory environments, and clinical adoption characteristics.

To maintain analytical integrity, the summary excludes market sizing, market share, revenue estimation, growth forecasting, and company-specific claims. The focus remains on evidence-backed drivers, clinical needs, technology shifts, adoption conditions, and strategic implications for stakeholders in neonatal intensive care respiratory devices.

Conclusion: Advancing Safer and More Equitable Neonatal Respiratory Care

Neonatal intensive care respiratory devices are evolving from standalone life-support equipment into integrated, data-enabled, and physiology-specific systems designed to improve safety for the most vulnerable patients. The strongest opportunities are tied to non-invasive respiratory support, precision oxygen management, neonatal-specific ventilation modes, advanced monitoring, transport readiness, infection prevention, and validated AI-assisted decision support.

Regional needs vary significantly, from advanced NICU modernization in high-income health systems to essential oxygen and CPAP access in settings with limited neonatal infrastructure. Across all regions, successful adoption depends on more than device availability; it requires training, maintenance, consumables, clinical protocols, biomedical support, and alignment with newborn health priorities.

Industry stakeholders that combine clinical evidence, neonatal-centered design, regulatory discipline, and implementation support will be best positioned to contribute to safer respiratory care. The future of neonatal respiratory devices will be defined by technologies that help clinicians deliver gentler ventilation, more stable oxygenation, earlier intervention, and equitable access to high-quality newborn respiratory support.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neonatal Intensive Care Respiratory Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Continuous Positive Airway Pressure Devices
  • 7.3. Conventional Ventilators
  • 7.4. High-Frequency Ventilators
  • 7.5. Oxygen Hoods

8. Neonatal Intensive Care Respiratory Devices Market, by Technology

  • 8.1. Introduction
  • 8.2. Invasive Respiratory Support
    • 8.2.1. Conventional Mechanical Ventilation
      • 8.2.1.1. Dual-Controlled Ventilation
      • 8.2.1.2. Pressure Controlled Ventilation
      • 8.2.1.3. Volume Controlled Ventilation
    • 8.2.2. High-Frequency Oscillatory Ventilation
  • 8.3. Non-Invasive Respiratory Support
    • 8.3.1. Continuous Positive Airway Pressure Therapy
    • 8.3.2. Non-Invasive Positive Pressure Ventilation

9. Neonatal Intensive Care Respiratory Devices Market, by Mode

  • 9.1. Introduction
  • 9.2. Dual-Controlled Ventilation
  • 9.3. Pressure Controlled Ventilation
  • 9.4. Volume Controlled Ventilation

10. Neonatal Intensive Care Respiratory Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Clinics
  • 10.3. Hospitals
  • 10.4. Specialty Care Centers

11. Neonatal Intensive Care Respiratory Devices Market, by Application

  • 11.1. Introduction
  • 11.2. Apnea Monitoring
  • 11.3. Oxygen Therapy
  • 11.4. Weaning Support

12. Neonatal Intensive Care Respiratory Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Neonatal Intensive Care Respiratory Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neonatal Intensive Care Respiratory Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Allied Healthcare Products Inc.
  • 16.2. Atom Medical Corporation
  • 16.3. AVI Healthcare Private Limited
  • 16.4. Becton, Dickinson and Company
  • 16.5. Dragerwerk AG & Co. KGaA
  • 16.6. Edwards Lifesciences Corporation
  • 16.7. Fanem Ltda
  • 16.8. Fisher & Paykel Healthcare Corporation Limited
  • 16.9. GaleMed Corporation
  • 16.10. GE HealthCare Technologies Inc.
  • 16.11. Getinge AB
  • 16.12. Hamilton Medical AG
  • 16.13. ICU Medical Inc.
  • 16.14. Inspiration Healthcare Group plc
  • 16.15. Koninklijke Philips N.V.
  • 16.16. Masimo Corporation
  • 16.17. Medin Medical Innovations GmbH
  • 16.18. Medtronic plc
  • 16.19. Mindray Medical International Limited
  • 16.20. Natus Medical Incorporated
  • 16.21. Nihon Kohden Corporation
  • 16.22. Nonin Medical Inc.
  • 16.23. Phoenix Medical Systems Private Limited
  • 16.24. ResMed Inc.
  • 16.25. Sechrist Industries Inc.
  • 16.26. Siare Engineering International Group s.r.l.
  • 16.27. SLE Limited
  • 16.28. Utah Medical Products Inc.
  • 16.29. Vyaire Medical Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONVENTIONAL VENTILATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONVENTIONAL VENTILATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONVENTIONAL VENTILATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-FREQUENCY VENTILATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-FREQUENCY VENTILATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-FREQUENCY VENTILATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OXYGEN HOODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OXYGEN HOODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OXYGEN HOODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INVASIVE RESPIRATORY SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INVASIVE RESPIRATORY SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INVASIVE RESPIRATORY SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONVENTIONAL MECHANICAL VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONVENTIONAL MECHANICAL VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONVENTIONAL MECHANICAL VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DUAL-CONTROLLED VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DUAL-CONTROLLED VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DUAL-CONTROLLED VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PRESSURE CONTROLLED VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PRESSURE CONTROLLED VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PRESSURE CONTROLLED VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VOLUME CONTROLLED VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VOLUME CONTROLLED VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VOLUME CONTROLLED VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIGH-FREQUENCY OSCILLATORY VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIGH-FREQUENCY OSCILLATORY VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIGH-FREQUENCY OSCILLATORY VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-INVASIVE RESPIRATORY SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-INVASIVE RESPIRATORY SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-INVASIVE RESPIRATORY SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-INVASIVE POSITIVE PRESSURE VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON-INVASIVE POSITIVE PRESSURE VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-INVASIVE POSITIVE PRESSURE VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DUAL-CONTROLLED VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DUAL-CONTROLLED VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DUAL-CONTROLLED VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PRESSURE CONTROLLED VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PRESSURE CONTROLLED VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PRESSURE CONTROLLED VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VOLUME CONTROLLED VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VOLUME CONTROLLED VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VOLUME CONTROLLED VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SPECIALTY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SPECIALTY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SPECIALTY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL APNEA MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL APNEA MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL APNEA MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OXYGEN THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OXYGEN THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OXYGEN THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL WEANING SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL WEANING SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL WEANING SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 143. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 144. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 145. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 170. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 171. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 172. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 179. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 180. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 181. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. CANADA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. CANADA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. CANADA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. CANADA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 198. CANADA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 199. CANADA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 200. CANADA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 201. CANADA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. CANADA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. MEXICO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. MEXICO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. MEXICO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. MEXICO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 207. MEXICO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 208. MEXICO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 209. MEXICO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 210. MEXICO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. MEXICO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. BRAZIL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. BRAZIL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. BRAZIL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. BRAZIL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 216. BRAZIL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 217. BRAZIL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 218. BRAZIL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 219. BRAZIL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. BRAZIL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED KINGDOM NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED KINGDOM NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED KINGDOM NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED KINGDOM NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED KINGDOM NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED KINGDOM NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED KINGDOM NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED KINGDOM NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED KINGDOM NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GERMANY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. GERMANY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. GERMANY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. GERMANY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 234. GERMANY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 235. GERMANY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 236. GERMANY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 237. GERMANY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. GERMANY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. FRANCE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. FRANCE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. FRANCE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. FRANCE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 243. FRANCE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 244. FRANCE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 245. FRANCE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 246. FRANCE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. FRANCE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. RUSSIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. RUSSIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. RUSSIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. RUSSIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 252. RUSSIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 253. RUSSIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 254. RUSSIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 255. RUSSIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. RUSSIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. ITALY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. ITALY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. ITALY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. ITALY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 261. ITALY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 262. ITALY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 263. ITALY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 264. ITALY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. ITALY NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. SPAIN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. SPAIN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. SPAIN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. SPAIN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 270. SPAIN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 271. SPAIN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 272. SPAIN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 273. SPAIN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. SPAIN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. INDIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. INDIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. INDIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. INDIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 288. INDIA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MEC